Which hedge funds own EPRX? EUPRAXIA PHARMACEUTICALS INC, Q2 2026 13F holders
7 of the hedge funds tracked by WhaleCreep disclosed a position in EPRX (EUPRAXIA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $23.0m in total. The largest holder by portfolio weight is Rubric Capital Management at 0.1% of its book. 2 managers opened a new position this quarter: Brevan Howard Capital Management, Millennium Management.
7tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold EPRX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Rubric Capital Management | Q2 2026 | 0.1% | $5.7m | 867,424 | 26% | added |
| Woodline Partners | Q2 2026 | 0.0% | $4.9m | 746,864 | 70% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $4.8m | 730,284 | -25% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $229.8k | 34,767 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $2.9m | 441,586 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $3.3m | 502,011 | 118% | added |
| Marshall Wace | Q2 2026 | 0.0% | $1.0m | 158,133 | 0% | held |
How has hedge fund ownership of EPRX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $23.0m |
| Q1 2026 | 5 | $18.0m |
| Q4 2025 | 1 | $5.4m |
Counts every tracked manager that disclosed EPRX in that quarter's filing, including managers that have since stopped filing.